NRL-0301

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNRL-0301
Drug Alias Namenon-alcoholic steatohepatitis agent (Norgine)NRL-0301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNorgine BV
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNorgine BV
Active IndicationsN/A
Inactive IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A